Vistin Pharma - Call Transcript 2020

Vistin Pharma ASA: Invitation to Q4 2019 conference call

Oslo, Norway, 19 February 2020

Vistin Pharma ASA will release its fourth quarter 2019 results on

Friday 28 February 2020.

Vistin Pharma will host a conference call for all shareholders and interested

parties on 28 February at 08:30 CET. There will be a Q&A session following the

management discussion.

The conference call will be held in Norwegian.

The fourth quarter conference call will be available via web and audio through

the following access points:

Telephone conference:

Confirmation Code:........ 6394327

International Dial-In:........ +44 (0) 2071 928000

Norway, Oslo:................ +47 23960264

United States, New York: +16315107495

Webcast:

https://edge.media-server.com/mmc/p/zxt9i6wn

*****

For further information, please contact:

Hans Lysheim

Interim CFO

+47 93404313

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

AI assistant